Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P840024/S099

Nucleus 22 Cochlear Implant System

Cochlear Americas · Decision date Sep 28, 2026

MEDTECHLEDGER EXPLANATIONP840024/S099

What did the FDA decide?

The FDA record for P840024/S099, dated 2026-09-28 and filed by Cochlear Americas, is a 30-day notice supplement whose stated reason is a process change involving a manufacturer, sterilizer, packager or supplier. The submitted statement describes a change to the joining process in the manufacturing of the NEUF Child Lock component in Cochlear Sound Processors, with the device category listed as cochlear implant and product code MCM.

The P840024 identifier ties this supplement to the existing PMA record rather than constituting approval of the whole Nucleus 22 Cochlear Implant System. The statement does not describe the prior joining process, the changed parameters, validation data, or whether the NEUF Child Lock component is itself a sound processor part, so the technical extent of the change remains unspecified here. The notice reports a manufacturing process adjustment; it is not independent evidence of safety or clinical effectiveness.

FDA approval order statement

a change to the joining process in the manufacturing of the NEUF Child Lock component in Cochlear Sound Processors
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Ear, Nose, Throat
Decision date
Sep 28, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P840024/S099
Regulatory pathway
PMA supplement
Product code
MCM
Decision code
OK30
Decision date
Sep 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implant, cochlear.

Product code
MCM
FDA device class
3

For the original device and its historical approval scope, see PMA P840024. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P840024 · Original PMA

    NUCLEUS MULTICHANNEL IMPLANTABLE HEARING PROSTHESI

  2. P840024/S099 received

    Application receipt date recorded by FDA.

  3. P840024/S099 · FDA decision

    30-Day Notice

Timeline entries are records held by MedtechLedger for P840024. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P840024

Product / regulatory recordCompanyPathwayDecision dateSource
Cochlear AmericasPMA approvalOct 31, 1985FDA

Explore the linked device profile

Other records with product code MCM

Product / regulatory recordCompanyPathwayDecision dateSource
Med-El Corp.PMA supplementOct 9, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Cochlear AmericasPMA supplementSep 28, 2026FDA
Advanced BionicsPMA supplementSep 18, 2026FDA
Advanced BionicsPMA supplementSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Cochlear Americas

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
10350 Park Meadows Dr., Lone Tree, CO, 80124

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records